Nurix Therapeutics, Inc. Common stock Share Price
NASDAQ: NRIXHealthcare
Live Nurix Therapeutics, Inc. Common stock Share Price Chart
O H L
Nurix Therapeutics, Inc. Common stock Performance Overview
Days Range
▼
$25.35Low
$25.68High
Markets Today
| Previous Close | $25.50 |
|---|---|
| Open | $25.64 |
| Volume | 394,171 |
| Day's Range | $25.35 - $25.68 |
| 52W Range | $8.20 - $28.23 |
| Market Cap | $2.61 B |
Historical Performance
| 1M Returns | -5.31 |
|---|---|
| 3M Returns | +45.30 |
| 6M Returns | +69.44 |
| 1Y Returns | +184.28 |
| 5Y Returns | -29.17 |
| 10Y Returns | NA |
Nurix Therapeutics, Inc. Common stock Fundamentals
| Market Cap | $2.61 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $83.98 M |
| ROE TTM | -0.50 |
| EPS TTM | $-3.45 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.48 |
| EBITDA | $-276.93 M |
| Profit Margin | -314.90 |
| Market Cap | $2.61 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $83.98 M |
| ROE TTM | -0.50 |
| EPS TTM | $-3.45 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 6.48 |
| EBITDA | $-276.93 M |
| Profit Margin | -314.90 |
Nurix Therapeutics, Inc. Common stock Profit & Loss
Quarterly
| Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $18.45 M | $44.06 M | $7.89 M | $13.58 M | $6.25 M | $9.04 M |
| Gross Profit + | $18.45 M | $44.06 M | $7.89 M | $13.58 M | $6.25 M | $9.04 M |
| Operating Income | -$62.86 M | -$48.32 M | -$91.39 M | -$83.09 M | -$92.50 M | -$94.20 M |
| EBITDA | -$60.51 M | -$46.08 M | -$89.36 M | -$80.97 M | -$90.30 M | -$91.95 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $2.35 M | $2.24 M | $2.03 M | $2.12 M | $2.20 M | $2.25 M |
| Income Before Tax | -$56.35 M | -$42.70 M | -$86.42 M | -$78.22 M | -$87.17 M | -$89.81 M |
| Income Tax Expense | $0 | $760.00 K | $0 | $0 | $0 | -$271.00 K |
| Net Income + | -$56.35 M | -$43.46 M | -$86.42 M | -$78.22 M | -$87.17 M | -$89.53 M |
| Net Profit Margin | -305.38% | -98.66% | -1094.77% | -576.13% | -1394.34% | -990.1% |
Nurix Therapeutics, Inc. Common stock Financials Balance Sheet In USD
Quarterly
| Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $76.00 K | $76.00 K | $77.00 K | $102.00 K | $103.00 K | $104.00 K |
| Reserve & Surplus | -$794.89 M | -$838.60 M | -$924.89 M | -$1.00 B | -$1.09 B | -$1.18 B |
| Non-Current Liabilities | $44.14 M | $68.34 M | $67.87 M | $62.92 M | $63.04 M | $60.89 M |
| Current Liabilities | $89.99 M | $75.61 M | $82.35 M | $86.47 M | $92.20 M | $72.02 M |
| Total Liabilities | $134.13 M | $143.95 M | $150.22 M | $149.39 M | $155.24 M | $132.91 M |
| Fixed Assets | $18.45 M | $18.77 M | $20.50 M | $22.49 M | $21.70 M | $20.01 M |
| Current Assets | $563.70 M | $515.33 M | $440.60 M | $606.82 M | $554.39 M | $456.48 M |
| Total Assets | $615.04 M | $591.55 M | $522.47 M | $688.13 M | $636.13 M | $535.54 M |
Nurix Therapeutics, Inc. Common stock Cash Flow
Quarterly
| Feb 2025 | May 2025 | Aug 2025 | Nov 2025 | Feb 2026 | May 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$56.35 M | -$43.46 M | -$86.42 M | -$78.22 M | -$87.17 M | -$89.53 M |
| Operating Cash Flow | -$61.09 M | -$63.16 M | -$57.38 M | -$67.83 M | -$71.91 M | -$96.57 M |
| Investing Cash Flow | $25.53 M | $71.50 M | $50.48 M | $346.00 K | -$123.83 M | $93.00 M |
| Financing Cash Flow | $1.47 M | $6.00 K | $1.16 M | $236.01 M | $19.98 M | $66.00 K |
| Change in Cash | -$34.08 M | $8.34 M | -$5.75 M | $168.52 M | -$175.76 M | -$3.51 M |
Nurix Therapeutics, Inc. Common stock Return Calculator
The Nurix Therapeutics, Inc. Common stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,047
Invested Amount$10,000
Est. Returns$-2,953
About Nurix Therapeutics, Inc. Common stock
Nurix Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and potential commercialization of targeted protein degradation therapies for cancer and inflammatory diseases. It utilizes an integrated discovery platform that incorporates artificial intelligence and ligase expertise to support its research activities. The company's pipeline includes Bexobrutideg (NX-5948), Zelebrudomide (NX-2127), NX-1607 and BRAF degrader. These drug candidates target specific proteins involved in immune and cancer-related pathways. It operates in a single business segment.
Popular Stocks
FAQs
What is the share price of Nurix Therapeutics, Inc. Common stock today?
Nurix Therapeutics, Inc. Common stock (NRIX) share price as of September 18, 2026 is $25.37. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Nurix Therapeutics, Inc. Common stock?
Yes, Indian Investors can invest in the Nurix Therapeutics, Inc. Common stock (NRIX) Share by opening an international trading account with Angel One.
How can I purchase Nurix Therapeutics, Inc. Common stock shares in India?
Purchasing Nurix Therapeutics, Inc. Common stock (NRIX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Nurix Therapeutics, Inc. Common stock (NRIX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Nurix Therapeutics, Inc. Common stock?
Yes, you can purchase fractional shares of Nurix Therapeutics, Inc. Common stock (NRIX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Nurix Therapeutics, Inc. Common stock?
The market capitalization of Nurix Therapeutics, Inc. Common stock on September 18, 2026, is $2.61 B.
In which sector Nurix Therapeutics, Inc. Common stock belongs?
Nurix Therapeutics, Inc. Common stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Nurix Therapeutics, Inc. Common stock stocks?
In order to invest in Nurix Therapeutics, Inc. Common stock (NRIX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
